1 year return (CAGR)
136.40%
Abcellera Biologics Inc Exchange (NASDAQ, USD)
ABCL
13.64
+0.81 (+6.31%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
47.27%
5 year return (CAGR)
-3.19%
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
4.42B
Price/Sales
66.79
Ent value
4.71B
Price/Book
4.93
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 12.67 |
| Daily high | 13.65 |
| Daily low | 12.65 |
| Daily Volume | 3.04M |
| All-time high | 53.20 |
| 1y analyst estimate | 16.70 |
| Beta | 1.32 |
| EPS (TTM) | -0.54 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 24 Feb 2026 |
Downside potential
Loading...
Downside potential data
| ABCL | S&P500 | |
| Current price drop from All-time high | -74.36% | -0.87% |
| Highest price drop | -96.37% | -56.47% |
| Date of highest drop | 8 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -81.70% | -10.65% |
| Avg time to new high | 246 days | 12 days |
| Max time to new high | 1443 days | 1805 days |
News
